Merck Stops Developing Both Of Its COVID-19 Vaccine Candidates

Pharmaceutical company Merck says it is shelving its two COVID-19 vaccine candidates, saying that the results of clinical trials fell short of its goals.

Merck, which previously made an Ebola vaccine, had been seen as a serious contender in the worldwide race to come up with an answer to the coronavirus.

(Image credit: Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

You May Also Like